These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1340 related items for PubMed ID: 11317516

  • 1. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
    Mide SM, Huygens P, Bozzini CE, Fernandez Pol JA.
    In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of erythroid and myeloid stem cells in post-hypoxia polycythaemia.
    Peschle C, Magli MC, Cillo C, Lettieri F, Genovese A, Pizzella F, Soricelli A.
    Br J Haematol; 1977 Nov; 37(3):345-52. PubMed ID: 603766
    [Abstract] [Full Text] [Related]

  • 3. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythropoietic precursors in mice under erythropoietic stimulation and suppression.
    Hara H, Ogawa M.
    Exp Hematol; 1977 Mar; 5(2):141-8. PubMed ID: 844518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY, Huang JY.
    Nephron; 1998 Mar; 79(2):142-7. PubMed ID: 9647492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
    Takatsuki F, Miyasaka Y, Kikuchi T, Suzuki M, Hamuro J.
    Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
    [Abstract] [Full Text] [Related]

  • 16. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
    Goris H, Bungart B, Loeffler M, Schmitz S, Nijhof W.
    Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG.
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
    Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L.
    Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.